Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-04-21
2008-08-05
Chen, Stacy B (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C424S231100
Reexamination Certificate
active
07407752
ABSTRACT:
The methods disclosed herein are of use for the treatment of a wide variety of diseases. In particular, the methods provide for the targeting of a transcription altering agent to a specific target site of a viral genome in order to inactivate the virus. In addition, the methods provide for a triplex-forming oligonucleotide capable of interacting with a target site in a viral genome in order to alter transcription. The methods of the present invention may be used against viral pathogens or agents of bioterrorism.
REFERENCES:
Jendis et al. AIDS Research and Human Retroviruses, 1998, 14(11):999-1005.
Vasquez, Karen M.; Narayanan, Latha; Glazer Peter M. Specific Mutations Induced by Triplex-Forming Oligonucleotides in Mice, Science, Oct. 20, 2000, 530-533, v. 290.
Chan, Phillip P.; Glazer, Peter M. Triplex DNA: fundamentals, advances, and potential applications for gene therapy, J. Mol. Med., 1997, 267-282, v.75.
Ebbinghaus, S.W. et al. Inhibition of transcription elongation in the HER-2
eu coding sequence by tiplex-directed covalent modification . . . , Biochem, 1999, 619-628, v. 38.
Majumdar, A. et al. Targeted gene knockout mediated by triple helix forming oligonucleotides, Nature Genetics, Oct. 1998, 212-214, v. 20.
Barre, F.-X. et al. Covalent crosslinks introduced via a triple helix-forming oligonucleotide coupled to psoralen . . . , Nucleic Acids Research, 1999, 743-749, v. 27(3).
Block, Timothy M.; Hill, James M. The latency associated transcripts (LAT) of herpes simplex virus: still no end in sight, J. NeuroVirology, 1997, 313-321, v. 3.
McShan, W. M. et al. Inhibition of Transcription of HIV-1 in Infected Human Cells by Oligodeoxynucleotides . . . , J. Biological Chem., Mar. 15, 1992, 5712-5721, v. 267(8).
Helene, C. et al. Control of Gene Expression by Triple Helix-Forming Oligonucleotides: The Antigene Strategy, Annals New York Academy of Sciences, Oct. 28, 1992, 27-36, v. 660.
Oh, D.H. et al. Binding and Photoreactivity of Psoralen Linked to Triple Helix-Forming Oligonucleotides, Photochemistry and Photobiology, 2000, 298-307, v. 72(3).
Cooney, M. et al. Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene in Vitro, Science, Jul. 22, 1988, 456-459, v. 241.
Felber, T.D. et al. Photodynamic Inactivation of Herpes Simplex, JAMA, Jan. 15, 1973, 289-292, v. 223(3).
Aurelian, L. et al. Herpes Simplex Virus Type 2 Growth and Latency Reactivation by Cocultivation . . . , Antisense & Nucleic Acid Drug Development, 2000, 77-85, v. 10.
Yoon, K. et al. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric . . . , Proc. Natl. Acad. Sci., Mar. 1996, 2071-2076, v. 93.
Jing, N. et al. Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic Drug. J. Biological Chem., Dec. 25, 1998, 34992-34999, v. 273(52).
Shogan, B. et al. Virucidal Activity of a GT-Rich Oligonucleotide Against HSV Mediated by GB. 29th International Herpesvirus Workshop, Jul. 25-30, 2004. abstract.
Morales-Rojas, H. and Kool, E.T. A Porphyrin C-Nucleoside Incorporated into DNA. Organic Letters, 2002, 4377-4380, v. 4(25).
Glazer Peter M.
Grissom Charles B.
Herpin Geoff
Jones Brandt B.
Kriesel John D.
Chen Stacy B
McCallum Esq. Jennifer M.
The McCallum Law Firm, P.C.
University of Utah Research Foundation
Yale University
LandOfFree
Oligonucleotide complexes for use as anti-viral therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide complexes for use as anti-viral therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide complexes for use as anti-viral therapeutics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997803